@fiercebiotech : Valiltramiprosate was no better than placebo at slowing cognitive decline in the phase 3 trial, causing the study—which included 325 people with early Alzheimer’s—to miss its primary endpoint. fiercebiotech.com/biotech/alzheo… • TwiCopy

FierceBiotech

@fiercebiotech

+ Follow

The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.

ID: 18294197

linkhttp://FierceBiotech.com calendar_today21-12-2008 22:21:58

29,29K Tweet

101,101K Takipçi

636 Takip Edilen

FierceBiotech

@fiercebiotech

4 months ago

Valiltramiprosate was no better than placebo at slowing cognitive decline in the phase 3 trial, causing the study—which included 325 people with early Alzheimer’s—to miss its primary endpoint. fiercebiotech.com/biotech/alzheo…

thumb_up_off_alt9

chat_bubble_outline0

repeat3

shareShare